Atlas Trials

An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly

Clinical trial NCT01995734 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT01995734
Sponsor
Novartis Pharmaceuticals
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Acromegaly

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.